BMS-986523, BMS-986523 clinical trials

A Phase 1/2a, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Malignancies

This study is testing a new medicine, BMS-986523, for people with advanced cancers. Doctors want to see if it's safe, how the body handles it, and if it helps shrink tumours, both alone and with other treatments.